Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

When Your Own Immune System Attacks Your Eyes / Biotechnology Company Amgen Relies on Research for Patients with Rare Diseases

Summary by presseportal.de
Amgen GmbH [Newsroom]Munich (ots) - Endocrine orbitopathy is a rare and potentially viscous autoimmune disease. With a targeted research approach based on its "biology first" principle, Amgen is building its engagement in the field of rare ... Continue reading here...Original content of: Amgen GmbH, transmitted by news aktuell

1 Articles

presseportal.depresseportal.de
Lean Right

When Your Own Immune System Attacks Your Eyes / Biotechnology Company Amgen Relies on Research for Patients with Rare Diseases

Amgen GmbH [Newsroom]Munich (ots) - Endocrine orbitopathy is a rare and potentially viscous autoimmune disease. With a targeted research approach based on its "biology first" principle, Amgen is building its engagement in the field of rare ... Continue reading here...Original content of: Amgen GmbH, transmitted by news aktuell

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

presseportal.de broke the news in on Thursday, March 12, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Amgen icon

Amgen

Research icon

Research

Munich icon

Munich

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal